[go: up one dir, main page]

AU5904101A - Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides - Google Patents

Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides

Info

Publication number
AU5904101A
AU5904101A AU5904101A AU5904101A AU5904101A AU 5904101 A AU5904101 A AU 5904101A AU 5904101 A AU5904101 A AU 5904101A AU 5904101 A AU5904101 A AU 5904101A AU 5904101 A AU5904101 A AU 5904101A
Authority
AU
Australia
Prior art keywords
polynucleotides
polypeptides
methods
growth factor
stem cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5904101A
Inventor
Tom Y Tang
Ivan Labat
John S Tillinghast
Ankura Sinku
Chenghua Liu
Radoje T Drmanac
Birgit Stache-Crain
Mark Dickson
Nancy K Mize
Mitsuo Nishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Hyseq Inc
Original Assignee
Kirin Brewery Co Ltd
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd, Hyseq Inc filed Critical Kirin Brewery Co Ltd
Publication of AU5904101A publication Critical patent/AU5904101A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU5904101A 2000-04-05 2001-04-05 Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides Pending AU5904101A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54377400A 2000-04-05 2000-04-05
US21573300P 2000-06-28 2000-06-28
US75756201A 2001-01-09 2001-01-09
US26661401P 2001-02-05 2001-02-05
PCT/US2001/011208 WO2001077169A2 (en) 2000-04-05 2001-04-05 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides

Publications (1)

Publication Number Publication Date
AU5904101A true AU5904101A (en) 2001-10-23

Family

ID=27499020

Family Applications (1)

Application Number Title Priority Date Filing Date
AU5904101A Pending AU5904101A (en) 2000-04-05 2001-04-05 Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides

Country Status (5)

Country Link
EP (1) EP1268543A2 (en)
JP (1) JP2003530124A (en)
AU (1) AU5904101A (en)
CA (1) CA2405104A1 (en)
WO (1) WO2001077169A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7411052B2 (en) 2001-03-05 2008-08-12 Nuvelo, Inc. Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
JP2005514917A (en) * 2001-10-03 2005-05-26 インサイト・ゲノミックス・インコーポレイテッド Secreted protein
US9081011B2 (en) 2003-10-10 2015-07-14 Deutsches Krebsforschungszentrum Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt
KR20070007289A (en) * 2004-01-27 2007-01-15 기린 비루 가부시키가이샤 Growth factors of the stomach and their uses
US7541431B2 (en) 2005-09-07 2009-06-02 Maine Medical Center Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto
JP2009511017A (en) * 2005-10-07 2009-03-19 ヌベロ インコーポレーティッド Stem cell factor-like protein SCFA1 and uses thereof
HUE028379T2 (en) 2006-09-29 2016-12-28 Oncomed Pharm Inc Compositions and methods for diagnosing and treating cancer
ES2564794T5 (en) 2006-10-20 2019-03-14 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts R-spondins as modulators of angiogenesis and vasculogenesis
WO2008075796A1 (en) * 2006-12-21 2008-06-26 Kyowa Hakko Kirin Co., Ltd. Agent for promoting recovery from blood cell depletion
ES2553169T5 (en) 2007-07-02 2023-11-30 Oncomed Pharm Inc Compositions and methods for the treatment and diagnosis of cancer
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
RU2555545C2 (en) 2009-02-03 2015-07-10 Конинклейке Недерландсе Академи Ван Ветенсаппен Culture medium for epithelial stem cells and organoids, containing thereof
US20120039912A1 (en) 2009-04-15 2012-02-16 Galapagos Sasu Rspondin-3 inhibition in bone disorders
US8551479B2 (en) 2010-09-10 2013-10-08 Oncomed Pharmaceuticals, Inc. Methods for treating melanoma
RU2014101669A (en) 2011-07-15 2015-09-20 Онкомед Фармасьютикалс, Инк. AGENTS BINDING R-SPONDIN PROTEINS (RSPO), AND WAYS OF THEIR APPLICATION
AU2013235600B2 (en) * 2012-03-21 2017-12-07 Dana-Farber Cancer Institute, Inc. Isolation and use of human lymphoid organ-derived suppressive stromal cells
US9181333B2 (en) 2012-07-13 2015-11-10 Oncomed Pharmaceuticals, Inc. RSPO3 binding agents and uses thereof
JP2017528523A (en) 2014-09-16 2017-09-28 オンコメッド ファーマシューティカルズ インコーポレイテッド Treatment of fibrotic diseases
CN108607101A (en) * 2018-05-04 2018-10-02 广西中医药大学附属瑞康医院 Application of the ZIP1 genes in preparing the product for inhibiting apoptosis of mesenchymal stem cell
CN111420034A (en) * 2019-01-08 2020-07-17 上海莱馥医疗科技有限公司 Mixed stem cell preparation for treating psoriasis and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0977853A1 (en) * 1997-04-25 2000-02-09 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2365247A1 (en) * 1999-03-19 2000-09-28 Human Genome Sciences, Inc. 49 human secreted proteins
CN1297930A (en) * 1999-11-29 2001-06-06 上海博容基因开发有限公司 Human thrombus protein 30 as one new kind of polypeptide and polynucleotides encoding this polypeptide
CA2399776A1 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2001077169A9 (en) 2002-12-19
WO2001077169A3 (en) 2002-07-04
JP2003530124A (en) 2003-10-14
CA2405104A1 (en) 2001-10-18
WO2001077169A2 (en) 2001-10-18
EP1268543A2 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
AU2001274871A1 (en) Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides
AU5904101A (en) Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides
HK1081225A1 (en) Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
IL145002A0 (en) Adipose-derived stem cells and lattices
EP1325953A4 (en) Method of culturing mesenchymal stem cells
AU4550901A (en) Production of foreign polypeptides in plants as viral coat protein fusions
AU6438901A (en) Protein translocation into plant cells
GB0026252D0 (en) Pluripotential stem cells
AU1154802A (en) Single cell electroporation
AU2001247880A1 (en) Methods to prepare and use epidermal stem cells
AU2001227385A1 (en) Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
GB0025088D0 (en) Stem cells
AU2002241189A1 (en) Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
AU2001259041A1 (en) Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
IL152799A0 (en) Methods for delivering polypeptides to cells
AU1782601A (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
AU2001232967A1 (en) Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU2002323137A1 (en) Methods and compositions for use in selectively producing a protein in telomerase expressing cells
AU8591901A (en) Materials and methods relating to endothelial cell growth inhibitors
AU2002360460A8 (en) Methods and materials relating to novel polypeptides and polynucleotides
AU2003259696A8 (en) Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
GB2364339B (en) Improvements in and relating to guttering
AU2001231288A1 (en) Methods and materials relating to matrix metalloprotease-like polypeptides and polynucleotides
AU2002359351A8 (en) Methods and materials relating to prokineticin-like polypeptides and polynucleotides